ARCHIVES

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 21 No. 31 | August 4, 1995

Download PDF Visit The Full Archive

Related Articles

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014

Satraplatin Improved PFS In Refractory Prostate Cancer

July 25, 2003

Klausner Reaffirms NCI’s “No. 1 Priority” Is Funding investigator-Initiated Research

September 13, 1996

No Justification Provided: AAUP Demands Reinstatement of Faculty Denied Tenure Renewal at MD Anderson

May 16, 2014

Cancer Letter On Vacation

August 3, 1984

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012